about
Effects of low dose aspirin (81 mg) on proliferating cell nuclear antigen and Amaranthus caudatus labeling in normal-risk and high-risk human subjects for colorectal cancerDose escalation of a curcuminoid formulationHuman papillomavirus in amniotic fluid.Pancreatic cancer serum detection using a lectin/glyco-antibody array methodRectal mucosal quantitative galactose oxidase-Schiff reaction as an early detection biomarker for colorectal cancer: comparison to fecal occult stool blood test.Psychosocial predictors of adherence to risk-appropriate cervical cancer screening guidelines: a cross sectional study of women in Ohio Appalachia participating in the Community Awareness Resources and Education (CARE) project.Development and initial feedback about a human papillomavirus (HPV) vaccine comic book for adolescents.Family history and perceptions about risk and prevention for chronic diseases in primary care: a report from the family healthware impact trial.Prevention of cervix cancer.Chemoprevention for colorectal cancer.Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system.A randomized feasibility trial of brief telephone counseling to increase fruit and vegetable intakesPhase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomitingFeasibility of using maternal cancer screening visits to identify adolescent girls eligible for human papillomavirus vaccinationPilot clinical study of the effects of ginger root extract on eicosanoids in colonic mucosa of subjects at increased risk for colorectal cancerDevelopment and evaluation of a PCR and mass spectroscopy (PCR-MS)-based method for quantitative, type-specific detection of human papillomavirusThe human gut microbiome as a screening tool for colorectal cancer.Using patient monetary incentives and electronically derived patient lists to recruit patients to a clinical trialEffect of preventive messages tailored to family history on health behaviors: the Family Healthware Impact Trial.Prostatic alpha-linolenic acid (ALA) is positively associated with aggressive prostate cancer: a relationship which may depend on genetic variation in ALA metabolism.Ohio Appalachian women's perceptions of the cost of cervical cancer screening.Quantitative analysis of single amino acid variant peptides associated with pancreatic cancer in serum by an isobaric labeling quantitative method.Lack of HPV 16 and 18 detection in serum of colposcopy clinic patients.Effects of vitamin E from supplements and diet on colonic α- and γ-tocopherol concentrations in persons at increased colon cancer risk.HPV prevalence among women from Appalachia: results from the CARE project.Phase II study of the effects of ginger root extract on eicosanoids in colon mucosa in people at normal risk for colorectal cancer.Large-scale identification of core-fucosylated glycopeptide sites in pancreatic cancer serum using mass spectrometry.Markers of systemic exposures to products of intestinal bacteria in a dietary intervention study.Age-group differences in human papillomavirus types and cofactors for cervical intraepithelial neoplasia 3 among women referred to colposcopyEffects of a Mediterranean Diet Intervention on Anti- and Pro-Inflammatory Eicosanoids, Epithelial Proliferation, and Nuclear Morphology in Biopsies of Normal Colon TissuePatterns of cellular and HPV 16 methylation as biomarkers for cervical neoplasia.A Mediterranean dietary intervention in persons at high risk of colon cancer: recruitment and retention to an intensive study requiring biopsies.Clinical utility of family history for cancer screening and referral in primary care: a report from the Family Healthware Impact Trial.Effect of low-fat diets on plasma levels of NF-κB-regulated inflammatory cytokines and angiogenic factors in men with prostate cancer.Family history assessment: impact on disease risk perceptions.Human papillomavirus (HPV) testing for normal cervical cytology in low-risk women aged 30-65 years by family physicians.Effects of ginger supplementation on cell-cycle biomarkers in the normal-appearing colonic mucosa of patients at increased risk for colorectal cancer: results from a pilot, randomized, and controlled trialMeasuring cervical cancer risk: development and validation of the CARE Risky Sexual Behavior Index.Recruitment of minority and underserved populations in the United States: the Centers for Population Health and Health Disparities experience.Acceptance of the HPV vaccine among women, parents, community leaders, and healthcare providers in Ohio Appalachia
P50
Q28168125-2E160449-324B-4843-B93E-9142AAAAB8B5Q33236898-489CACDB-7E3B-496C-9329-BF71D45FDD47Q33256322-5A90EC10-ECC5-47BC-9D75-1A093677A90EQ33391974-7B7869DA-6254-48C7-AB7A-CA68CFA83800Q33593920-05A6D93C-94F7-4095-817C-D21C1513EBC5Q33620692-C4CCA5CD-18E6-4947-B8C8-D82A77D468F5Q33645571-A941A6E8-F0AD-4954-A383-4EE9811565F5Q33679444-123AB95E-00B2-4B17-A8EE-EE840DA8C94AQ33902897-827AAC1F-88B8-40BC-883D-E732AB58F967Q33902908-68C08863-960B-459D-964E-AB2FFCED8635Q33918719-65D75E7C-E2E0-412B-B966-041F60E772AAQ33994554-40685373-86E1-4210-953A-6F3C48E774B0Q34038796-F49B3137-FBF8-45C3-B273-5476031B61E3Q34342811-23493446-25F6-4AD7-94C1-D7628F00F2E7Q34401631-636F9F33-14BA-4BFB-9E70-7205B8916EFFQ34420904-0D6EFC67-3CBF-4FE9-941A-2593F882A985Q34457985-0835724E-6212-4310-85D3-6BD46148AC1FQ34472253-6F738B77-C9D1-4696-871B-3D1A766CECA5Q34496337-D899F29D-1D0D-4141-955A-1E77102D6478Q34535007-0B033148-ED03-49DA-B5B3-3AC6737D4E0EQ34642416-D404D1AD-B557-4FAD-807A-53B7BA4022CBQ34669441-AC4C09F3-29C6-4EB1-819D-406C2EE5DCF9Q34687488-E8C997B0-114C-41C2-90AE-BDB2D0842F0CQ34799191-2337B3A2-C13A-4A91-BC2A-EBB979CD0F4CQ34983800-DB5D98CE-E6FD-4FCF-A2A6-97D5A238A6CBQ35529214-175FD001-DA83-42D1-A6D2-220D4903192FQ35542255-F1944386-3C00-4177-985A-266630F4F281Q35611937-0DA50086-3143-4587-893D-73FF5887A58EQ35699092-8AE950F8-2AC0-4B97-99BA-B6BB8250385AQ35802105-2D8439E5-2066-4033-AB63-B0EE4C1F2DF8Q36095106-6659B5CC-2302-4938-BE3F-42DAE9D7009BQ36129357-E5960E48-416B-4FF3-8751-3E403CB3A8AAQ36182632-EE580CFD-45BA-40AD-AD87-9C967DE6718BQ36224678-5455085B-4D0A-478D-AA9F-E6727452E162Q36250488-3D60DCDE-8062-403C-B9DA-110C49B42F8FQ36603654-E1122BA7-FFC5-494E-83E5-03027E03BD68Q36745418-5C29352F-D50C-4FCE-9C04-41340AC2B6B2Q36778922-CC97ED0F-B104-4DD7-88D5-8DA98F4E0808Q37097058-B244C15E-8709-42E2-A4C9-C71D9D4B277CQ37236967-75547980-067F-4A75-B9A0-51871B15FC6A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mack T Ruffin
@nl
Mack T Ruffin
@sl
Mack T. Ruffin
@en
Mack T. Ruffin
@es
type
label
Mack T Ruffin
@nl
Mack T Ruffin
@sl
Mack T. Ruffin
@en
Mack T. Ruffin
@es
prefLabel
Mack T Ruffin
@nl
Mack T Ruffin
@sl
Mack T. Ruffin
@en
Mack T. Ruffin
@es
P106
P1153
7006467693
P31
P496
0000-0001-8336-478X